Concurrent chemoradiotherapy improves both local control and overall survival in locally advanced head and neck cancer. When patients cannot be treated with concurrent chemoradiotherapy, a reasonable ...

November 16, 2009 — Cetuximab (Erbitux) plus radiotherapy should be considered a standard option in the treatment of locoregionally advanced squamous cell carcinoma of the head and neck, say ...

Patients with head and neck cancer treated with dysphagia-optimized intensity-modulated radiotherapy had improved swallow function compared with those treated with standard intensity-modulated ...

Recent results from the phase III NRG Oncology RTOG 0920 (NRG-RTOG 0920) trial assessing postoperative radiotherapy with or without concurrent cetuximab for selected patients with squamous cell cancer ...

Please provide your email address to receive an email when new articles are posted on . Hypofractionated radiotherapy proved noninferior to conventional radiotherapy in head and neck cancer subtype.

Concomitant Boost Radiation Plus Concurrent Cisplatin for Advanced Head and Neck Carcinomas: Radiation Therapy Oncology Group Phase II Trial 99-14 We conducted a retrospective cohort study comparing ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window In patients with ...

Treatment paradigms may soon be shifting in head and neck cancer, as recent research indicates that lower doses of chemoradiotherapy may be appropriate for some patients. Treatment paradigms may soon ...

Quality of Life in Patients With Metastatic Renal Cell Carcinoma Treated With Sunitinib or Interferon Alfa: Results From a Phase III Randomized Trial To investigate the impact of treatment-related ...